Topic

Health & ScienceNeutral

Drug trials, outbreaks and health policy: the science news with a market angle.

Mood across editions

4 editions
Positive 1Neutral 2Negative 1Archive

Earlier coverage

Every edition keeps its sources and the mood it reported at the time.

morning

Africa CDC sends Ebola experts to investigate Nigeria's first case in over a decade

Team led by Ebola co-discoverer Jean-Jacques Muyembe will probe how the Ugandan-born wife of a Swiss diplomat contracted Bundibugyo virus. Phase 3 trial of sacituzumab tirumotecan reduced risk of death by 33% and risk of progression or death by 41% versus chemotherapy. Intismeran plus Keytruda reduced risk of recurrence or death by 42% in Phase 3 melanoma trial.

Positive↑
weekly

Australia confirms first H5N1 bird flu case in mainland mammal

Australia confirmed its first H5N1 bird flu case in a mainland mammal after a long-nosed fur seal tested positive. US kindergarten vaccination coverage fell slightly with exemptions rising to a record 4.2%. Moderna and Merck reported that their personalized mRNA vaccine combined with Keytruda reduced melanoma recurrence risk in a successful Phase 3 trial. The CDC announced a multistate E. coli and Salmonella outbreak linked to alfalfa sprouts.

Neutral
weekly

US Reports 2,465 Measles Cases in 2026, Exceeding 2025 Total

As of August 6, 2026, 2,465 confirmed measles cases were reported to CDC with 38 new outbreaks and 94% of cases outbreak-associated. An outbreak tied to shredded iceberg lettuce from Mexico has sickened 6,358 people across 15 states including 278 hospitalizations and two deaths. There were 3,605 confirmed Ebola cases including 1,587 deaths as of July 30, 2026, with a crude case fatality ratio of 44% amid sustained transmission. No newer confirmed category development was available this period.

Negative

Other topics

Where each beat stood in the latest edition.